Anti-aging pill put to the test in healthy seniors
NCT ID NCT07195318
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a low-dose fisetin supplement (100 mg daily for 7 weeks) is safe and can reduce signs of inflammation and aging in healthy adults aged 50 and older. Researchers will measure changes in blood markers and track side effects. The goal is to see if this supplement, often advertised for anti-aging, actually works in people.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Department of Clinical Research, Copenhagen University Hospital Amager & Hvidovre
RECRUITINGHvidovre, 2650, Denmark
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new oral drug change future treatments? early safety trial begins
- Can brain scans unlock the secret to hearing in crowded rooms?
- Can a Light-Guided device make arterial sticks easier?
- Water workouts could be the key to back pain relief
- Could everyday disinfectants be harming us? a new study investigates
- Can a new drug keep the Heart's beat steady? trial puts verducatib to the test